Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GILD · against 20 other Healthcare companies of similar size
Ranked #19 of 21 · scores higher than 10% of peers · safety percentile 9
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)3 peers with a safety percentile of 0–9, including GILD · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GILD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 19 reported | 2.23× | 0.74× | 6% | 33% | |
| BetaLower is better · 21 reported | 0.33 | 0.35 | 60% | 33% | |
| Current ratioHigher is better · 21 reported | 1.26× | 1.27× | 45% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 134.5B USD | 72 | 70 | |
| 2 | 108.6B USD | 51 | 66 | |
| 3 | 155.7B USD | 43 | 64 | |
| 4 | 126.5B USD | 37 | 56 | |
| 5 | 285.2B USD | 35 | 63 | |
| 15 | 258.2B USD | 22 | 47 | |
| 16 | 162.93T ARS (≈$162.9B) | 21 | 63 | |
| 17 | 356.9B USD | 19 | 37 | |
| 18 | 126.1B USD | 12 | 62 | |
| 19 | 207.7B USD | 9 | 18 | |
| 20 | 249.4B USD | 9 | 55 | |
| 21 | 116.5B USD | 9 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score